Show simple item record

dc.contributor.authorGonzález Pujana, Ainhoa
dc.contributor.authorIgartua Olaechea, Manuela
dc.contributor.authorHernández Martín, Rosa María
dc.contributor.authorSantos Vizcaíno, Edorta
dc.date.accessioned2024-08-06T11:05:39Z
dc.date.available2024-08-06T11:05:39Z
dc.date.issued2024-10
dc.identifier.citationEuropean Journal of Pharmaceutical Sciences 201 : (2024) // Article ID 106858es_ES
dc.identifier.issn1879-0720
dc.identifier.urihttp://hdl.handle.net/10810/69173
dc.description.abstractProtein therapeutics hold immense promise for treating a wide array of diseases. However, their efficacy is often compromised by rapid degradation and clearance. The synthetic smectite clay Laponite emerges as a promising candidate for their sustained delivery. Despite its unique properties allow to load and release proteins mitigating burst release and extending their effects, precise control over Laponite-protein interactions remains challenging since it depends on a complex interplay of factors whose implication is not fully understood yet. The aim of this review article is to shed light on this issue, providing a comprehensive discussion of the factors influencing protein loading and release, including the physicochemical properties of the nanoclay and proteins, pH, dispersion buffer, clay/protein concentration and Laponite degradation. Furthermore, we thoroughly revise the array of bioactive proteins that have been delivered from formulations containing the nanoclay, highlighting Laponite-polymer nanocomposite hydrogels, a promising avenue currently under extensive investigation.es_ES
dc.description.sponsorshipThis work was supported by MCIU-Proyectos de Investigación Orientada (PID2021-122577OB-I00) and Eusko Jaurlaritza (Grupos Consolidados IT1448-22). Authors thank ICTS “NANBIOSIS” (Drug Formulation Unit, U10). A. Gonzalez-Pujana thanks the University of the Basque Country (UPV/EHU) for the postdoctoral grant (ESPDOC20/119). Fig. 1 was created with BioRender.com. Open Access funding provided by University of Basque Country (UPV/EHU).es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/PID2021-122577OB-I00es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectlaponitees_ES
dc.subjectnanoclayes_ES
dc.subjectdrug deliveryes_ES
dc.subjectproteines_ES
dc.subjecthydrogeles_ES
dc.titleLaponite nanoclays for the sustained delivery of therapeutic proteinses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license.es_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0928098724001702es_ES
dc.identifier.doi10.1016/j.ejps.2024.106858
dc.departamentoesFarmacia y ciencias de los alimentoses_ES
dc.departamentoeuFarmazia eta elikagaien zientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license.
Except where otherwise noted, this item's license is described as © 2024 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC license.